Regulatory circuitry governing fungal development, drug resistance, and disease
Pathogenic fungi have become a leading cause of human mortality due to the increasing
frequency of fungal infections in immunocompromised populations and the limited …
frequency of fungal infections in immunocompromised populations and the limited …
Fungal morphogenesis and host invasion
Many fungal pathogens undergo morphological transformations during host invasion.
However, the significance of this for fungal pathogenesis is not clear. Both yeast and hyphal …
However, the significance of this for fungal pathogenesis is not clear. Both yeast and hyphal …
Large‐scale essential gene identification in Candida albicans and applications to antifungal drug discovery
T Roemer, B Jiang, J Davison, T Ketela… - Molecular …, 2003 - Wiley Online Library
Candida albicans is the primary fungal pathogen of humans. Despite the need for novel
drugs to combat fungal infections [Sobel, JD (2000) Clin Infectious Dis 30: 652], antifungal …
drugs to combat fungal infections [Sobel, JD (2000) Clin Infectious Dis 30: 652], antifungal …
[PDF][PDF] Virulence factors of Candida species
YL Yang - Journal of Microbiology Immunology and Infection, 2003 - thecandidadiet.com
Cellular immunity is the primary host defense against microbial infections. In the healthy
host, opportunistic fungal pathogens are commensal fungi commonly colonizing human …
host, opportunistic fungal pathogens are commensal fungi commonly colonizing human …
Targeting Candida albicans filamentation for antifungal drug development
Candida albicans remains the main etiological agent of candidiasis, as this otherwise
normal commensal of humans is capable of causing active infection in immune-and …
normal commensal of humans is capable of causing active infection in immune-and …
Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans
Candida albicans, one of the pathogenic Candida species, causes high mortality rate in
immunocompromised and high-risk surgical patients. In the last decade, only one new class …
immunocompromised and high-risk surgical patients. In the last decade, only one new class …
Virulence in Candida species
K Haynes - Trends in microbiology, 2001 - cell.com
Candida species other than Candida albicans now account for up to 50% of deep
candidiasis cases, yet little attention has been paid to the virulence attributes of these fungi …
candidiasis cases, yet little attention has been paid to the virulence attributes of these fungi …
Candida Urinary Tract Infection: Pathogenesis
JF Fisher, K Kavanagh, JD Sobel… - Clinical Infectious …, 2011 - academic.oup.com
Candida species are unusual causes of urinary tract infection (UTI) in healthy individuals,
but common in the hospital setting or among patients with predisposing diseases and …
but common in the hospital setting or among patients with predisposing diseases and …
Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs
CG Pierce, JL Lopez-Ribot - Expert opinion on drug discovery, 2013 - Taylor & Francis
Introduction: Targeting pathogenetic mechanisms, rather than essential processes,
represents a very attractive alternative for the development of new antibiotics. This may be …
represents a very attractive alternative for the development of new antibiotics. This may be …
Transcript profiling in Candida albicans reveals new cellular functions for the transcriptional repressors CaTup1, CaMig1 and CaNrg1
AMA Murad, C d'Enfert, C Gaillardin… - Molecular …, 2001 - Wiley Online Library
The pathogenic fungus, Candida albicans contains homologues of the transcriptional
repressors ScTup1, ScMig1 and ScNrg1 found in budding yeast. In Saccharomyces …
repressors ScTup1, ScMig1 and ScNrg1 found in budding yeast. In Saccharomyces …